The move would onshore production of its rare disease products at an existing facility in Frederick and build a clinical research drug factory in Gaithersburg.
Categories:
Related Post
Office-to-housing conversions grew 28% last year
New York City led other cities in converted residential units by a wide margin, followed…
Connecticut starts $137M I-95 bridge replacements
The West Haven project aims to replace two aging spans and improve traffic flow in…
AECOM tapped as Los Angeles Olympics infrastructure partner
The Dallas-based firm will help plan and manage venues for the 2028 Olympic and Paralympic…